The import of vaccines for human use to China is projected to steadily increase over the next five years, rising from 365.51 thousand kilograms in 2024 to 402.41 thousand kilograms by 2028. Historically, in 2023, the import volume was lower than 365.51 thousand kilograms, marking a consistent upward trajectory as forecasted for 2024 and beyond. This growth trend indicates a robust demand for vaccines in the Chinese market, potentially driven by public health initiatives and a growing population.

Future trends to watch for:

Evolving vaccine technologies that might change import needs.
China's potential to expand domestic vaccine production, impacting imports.
Global vaccine supply chain developments affecting availability and pricing.
Policy changes within China regarding pandemic preparedness and essential medicine imports.